OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
16 mei 2012 - 07:15
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus publishes first quarter business update
Bericht
Highlights
- In January, we announced an expansion of a drug delivery technology evaluation contract with an existing client, a top-5 global pharmaceutical company
- We also announced a feasibility agreement with a leading US-based pharmaceutical company, aimed at developing a controlled release formulation of the client’s therapeutic compound for local delivery into joints
- And in February we announced a formulation development and manufacturing contract with Ferring Pharmaceuticals, a leading innovative pharmaceutical company.
Datum laatste update: 02 september 2024